Retraction notice to "Use of ivermectin in the treatment of Covid-19: A pilot trial" [Toxicol. Rep. 8 (2021) 505-510]

Toxicol Rep. 2022 May 2:9:1023. doi: 10.1016/j.toxrep.2022.04.009. eCollection 2022.

¹ Department of Medicine, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazil.
² Department of Molecular Pharmacology, Albert Einstein College of Medicine, 10461 Bronx, NY, United States.
³ University Hospital of the Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazil.
⁴ Department of Genetics and Evolution, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazil.

Abstract

[This retracts the article DOI: 10.1016/j.toxrep.2021.03.003.].